Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 1;7(1):75.
doi: 10.1186/s41747-023-00383-4.

Deep learning models for automatic tumor segmentation and total tumor volume assessment in patients with colorectal liver metastases

Affiliations

Deep learning models for automatic tumor segmentation and total tumor volume assessment in patients with colorectal liver metastases

Nina J Wesdorp et al. Eur Radiol Exp. .

Abstract

Background: We developed models for tumor segmentation to automate the assessment of total tumor volume (TTV) in patients with colorectal liver metastases (CRLM).

Methods: In this prospective cohort study, pre- and post-systemic treatment computed tomography (CT) scans of 259 patients with initially unresectable CRLM of the CAIRO5 trial (NCT02162563) were included. In total, 595 CT scans comprising 8,959 CRLM were divided into training (73%), validation (6.5%), and test sets (21%). Deep learning models were trained with ground truth segmentations of the liver and CRLM. TTV was calculated based on the CRLM segmentations. An external validation cohort was included, comprising 72 preoperative CT scans of patients with 112 resectable CRLM. Image segmentation evaluation metrics and intraclass correlation coefficient (ICC) were calculated.

Results: In the test set (122 CT scans), the autosegmentation models showed a global Dice similarity coefficient (DSC) of 0.96 (liver) and 0.86 (CRLM). The corresponding median per-case DSC was 0.96 (interquartile range [IQR] 0.95-0.96) and 0.80 (IQR 0.67-0.87). For tumor segmentation, the intersection-over-union, precision, and recall were 0.75, 0.89, and 0.84, respectively. An excellent agreement was observed between the reference and automatically computed TTV for the test set (ICC 0.98) and external validation cohort (ICC 0.98). In the external validation, the global DSC was 0.82 and the median per-case DSC was 0.60 (IQR 0.29-0.76) for tumor segmentation.

Conclusions: Deep learning autosegmentation models were able to segment the liver and CRLM automatically and accurately in patients with initially unresectable CRLM, enabling automatic TTV assessment in such patients.

Relevance statement: Automatic segmentation enables the assessment of total tumor volume in patients with colorectal liver metastases, with a high potential of decreasing radiologist's workload and increasing accuracy and consistency.

Key points: • Tumor response evaluation is time-consuming, manually performed, and ignores total tumor volume. • Automatic models can accurately segment tumors in patients with colorectal liver metastases. • Total tumor volume can be accurately calculated based on automatic segmentations.

Keywords: Artificial intelligence; Colorectal cancer; Deep learning; Liver neoplasms; Tomography (x-ray computed).

PubMed Disclaimer

Conflict of interest statement

CJAP has an advisory role for Nordic Pharma. HAM is a co-founder and shareholder of Nicolab.

JS is a member of the European Radiology Experimental Editorial Board. He has not taken part in the review or selection process of this article.

All remaining authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Patient selection of development cohort. CT Computed tomography, MRI Magnetic resonance imaging. *The patients excluded because of “MRI scan” had a MRI scan instead of a CT scan for their diagnostic work-up. For patients with “Missing CT,” the baseline or follow-up CT scan was not available. The error in segmentation software occurred in the IntelliSpace Portal software of Philips
Fig. 2
Fig. 2
Automatic segmentation process. a The liver U-net model receives the computed tomography scan as input image. The output of the liver U-net model is the automatic liver segmentation. b The automatic liver segmentation is used as the volume of interest for the tumor U-net model. The output of the tumor U-net model is the automatic tumor segmentation
Fig. 3
Fig. 3
Automatic segmentations of the liver and colorectal liver metastases in three patients of the development cohort. a, d, g Computed tomography scans before automatic segmentation. b, e, h Radiologist’s liver segmentation (pink) and automatic liver segmentation (blue). c, f, i Radiologist’s tumor segmentation (dark green) and automatic tumor segmentation (red)
Fig. 4
Fig. 4
Three-dimensional visualizations of the automatic segmentation of three patients in the development cohort in coronal posterior-anterior view. a–c Automatic liver segmentation (blue); automatic tumor segmentation (red)
Fig. 5
Fig. 5
Automatic segmentations in two patients of the external validation cohort. a, c Computed tomography scans before automatic segmentation. b, d Radiologist’s tumor segmentation (dark green) and automatic tumor segmentation (red)

References

    1. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European organization for research and treatment of cancer, national cancer institute of the United States, national cancer institute of Canada. J Natl Cancer Inst. 2000;92:205–216. doi: 10.1093/jnci/92.3.205. - DOI - PubMed
    1. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer. 2009;45:228–247. doi: 10.1016/j.ejca.2008.10.026. - DOI - PubMed
    1. Yoon SH, Kim KW, Goo JM, Kim DW, Hahn S. Observer variability in RECIST-based tumour burden measurements: a meta-analysis. Eur J Cancer. 2016;53:5–15. doi: 10.1016/j.ejca.2015.10.014. - DOI - PubMed
    1. Beaumont H, Evans TL, Klifa C, et al. Discrepancies of assessments in a RECIST 11 phase I.I clinical trial - association between adjudication rate and variability in images and tumors selection. Cancer Imaging. 2018;18:50. doi: 10.1186/s40644-018-0186-0. - DOI - PMC - PubMed
    1. Chun YS, Vauthey JN, Boonsirikamchai P, et al. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA. 2009;302:2338–2344. doi: 10.1001/jama.2009.1755. - DOI - PMC - PubMed

Publication types

Associated data